CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Common Stock Held in Treasury	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive (Loss) Income
Beginning balance (in shares) at Dec. 31, 2019			88,188,374		107,820
Beginning balance at Dec. 31, 2019	$ 627,111		$ 1	$ 764,769	$ (897)	$ (135,398)		$ (1,364)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for exercise of employee-based stock options (in shares)			143,760
Common stock issued for exercise of employee-based stock options	1,200			1,200
Issuance of common stock (in shares)			222,828
Issuance of common stock	2,050			2,050
Stock-based compensation	2,695			2,695
Net (loss) income	(52,293)					(52,293)
Unrealized gain (loss) on hedge transactions, net of tax	638							638
Foreign currency translation adjustment, net of tax	1,783							1,783
Ending Balance (in shares) at Dec. 31, 2020			88,554,962		107,820
Ending Balance at Dec. 31, 2020	583,184		$ 1	770,714	$ (897)	(187,691)		1,057
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for exercise of employee-based stock options (in shares)			6,093
Common stock issued for exercise of employee-based stock options	56			56
Issuance of common stock (in shares)			276,022
Issuance of common stock	2,429			2,429
Issuance of common stock in connection with initial public offering, net of offering costs, underwriting discounts and commissions (in shares)			4,760,000
Issuance of common stock in connection with initial public offering, net of offering costs, underwriting discounts and commissions	94,523		$ 48	94,475
Issuance of common stock in connection with forgiveness of promissory notes (in shares)			370,182
Issuance of common stock in connection with forgiveness of promissory notes	8,409			8,409
Capital contribution from Stockholder	15,576			15,576
Issuance of restricted shares, net of forfeitures and vesting (in shares)			1,779,716
Issuance of restricted shares, net of forfeitures and vesting			$ 19	(19)
Stock-based compensation	24,938			24,938
Net (loss) income	(18,527)					(18,527)
Unrealized gain (loss) on hedge transactions, net of tax	(270)							(270)
Foreign currency translation adjustment, net of tax	$ (694)							(694)
Ending Balance (in shares) at Dec. 31, 2021	95,746,975		95,746,975		107,820
Ending Balance at Dec. 31, 2021	$ 709,624		$ 68	916,578	$ (897)	(206,218)		93
Ending Balance (Accounting Standards Update 2016-13) at Dec. 31, 2021		$ (198)					$ (198)
Ending Balance (Accounting Standards Update 2016-02) at Dec. 31, 2021		$ 558					$ 558
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for exercise of employee-based stock options (in shares)			257,679
Common stock issued for exercise of employee-based stock options	2,416		$ 3	2,413
Issuance of common stock (in shares)			4,528
Issuance of common stock	0
Issuance of restricted shares, net of forfeitures and vesting (in shares)			1,648,118
Issuance of restricted shares, net of forfeitures and vesting	$ (2)		$ 5	(7)
Repurchase of common stock (in shares)	939,417		939,417		939,417
Repurchases of common stock	$ (13,962)				$ (13,962)
Stock-based compensation	23,805			23,805
Net (loss) income	19,410					19,410
Unrealized gain (loss) on hedge transactions, net of tax	0
Foreign currency translation adjustment, net of tax	$ (5,005)							(5,005)
Ending Balance (in shares) at Dec. 31, 2022	96,717,883		96,717,883		1,047,237
Ending Balance at Dec. 31, 2022	$ 736,646		$ 76	$ 942,789	$ (14,859)	$ (186,448)		$ (4,912)